# MAVYRET
> **NDA215110** · New Drug Application · Sponsor: ABBVIE · Approved 2021-06-10
## Drug
- **FDA Application Number:** NDA215110
- **Application type:** New Drug Application
- **Brand name:** MAVYRET
- **Generic name:** GLECAPREVIR AND PIBRENTASVIR
- **Active ingredients:** GLECAPREVIR; PIBRENTASVIR
- **Dosage form:** PELLETS
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** AbbVie Inc.
- **First approval:** 2021-06-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215110)
---
*AI Analytics · CC0 1.0*